Letter: need to re-evaluate non-invasive markers for staging fibrosis in chronic delta hepatitis

Aliment Pharmacol Ther. 2017 Feb;45(4):574-575. doi: 10.1111/apt.13890.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers
  • Fibrosis
  • Hepatitis C, Chronic*
  • Hepatitis D, Chronic*
  • Humans
  • Liver Cirrhosis

Substances

  • Biomarkers